MedTrace Logo

Local Anesthetic Treatments for Overactive Bladder

NCT00427648 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2020-03-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether alkalized lidocaine instilled into the bladder is effective in the treatment of overactive bladder (OAB).

Conditions

Interventions

DRUG

alkalinized xylocaine

30 cc of 1% xylocaine and 10 cc of 0.9% sodium bicarbonate, dosed twice a week for three weeks

DRUG

placebo

normal saline

Sponsors & Collaborators

  • Berlex Foundation

    collaborator OTHER

  • Frank Tu

    lead OTHER

Principal Investigators

  • Frank F. Tu, MD, MPH · Endeavor Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00427648 on ClinicalTrials.gov